| Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg. |
2017-01-23 |
| Merck KGaA. (1/23/17). "Press Release: Merck Announces Research Collaboration with Domain Therapeutics in Immuno-Oncology [Not intended for UK- or US-based media]". Darmstadt. |
2017-01-23 |
| Novasep S.A.. (3/7/17). "Press Release: Novasep Appoints Xavier de Saint Guilhem as Chief Financial Officer". Lyon. |
2017-03-07 |
| Transgene S.A.. (4/10/17). "Press Release: Transgene Announces Upcoming Investor Meetings and R&D Day". Strasbourg. |
2017-04-10 |
| Transgene S.A.. (4/12/17). "Press Release: Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial". Strasbourg. |
2017-04-12 |
| Transgene S.A.. (4/19/17). "Press Release: Marie Landel and Maya Said Nominated to be Independent Members of Transgene’s Board of Directors". Strasbourg. |
2017-04-19 |
| Transgene S.A.. (4/24/17). "Press Release: SillaJen and Transgene Announce the Enrollment of the First European Patient in Multinational Phase 3 Trial for Pexa-Vec in Advanced Liver Cancer". Seoul, San Francisco, CA & Strasbourg. |
2017-04-24 |
| Transgene S.A.. (4/25/17). "Press Release: Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer". New York, NY & Stras |
2017-04-25 |
| Anagenesis Biotechnologies. (5/18/17). "Press Release: Anagenesis Biotechnologies Announces Strategic Research Agreement with Boehringer Ingelheim to Discover Drugs for Chronic Muscle Diseases". Illkirch Graffenstaden. |
2017-05-18 |
| CiToxLab. (6/15/17). "Press Release: CiToxLab and KaLy-Cell Join Forces to Offer in vitro and ex vivo Testing for Hepatotoxicity and Metabolism". Evreux & Plobsheim. |
2017-06-15 |
| OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. |
2017-06-20 |
| Shimadzu Europe GmbH. (6/21/17). "Press Release: Shimadzu Has Acquired AlsaChim, a Specialist for High-quality Analytical Isotope Labeled Standards". |
2017-06-21 |
| Genfit S.A.. (6/23/17). "Press Release: Genfit Reaches a Critical Milestone towards the Development of a Non-invasive In Vitro Diagnostic (IVD) Test for NASH". Lille & Cambridge, MA. |
2017-06-23 |
| Servier. (6/29/17). "Press Release: Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic CAR-T". |
2017-06-29 |
| AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. |
2017-07-27 |
| Transgene S.A.. (9/11/17). "Press Release: Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)". Strasbourg. |
2017-09-11 |
| Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. |
2017-09-13 |
| Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. |
2017-09-19 |
| Transgene S.A.. (9/21/17). "Press Release: Transgene Launches Invir.IO, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses". Strasbourg. |
2017-09-21 |
| Transgene S.A.. (10/2/17). "Press Release: Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors". Strasbourg & Belfast. |
2017-10-02 |
| Enyo Pharma S.A.. (2/27/18). "Press Release: Enyo Pharma Strengthens Its Leadership Team with a NASH Expert and Announces that Its Phase Ib Trial in Chronic HBV Infected Patients is on Track with Its FXR Agonist EYP001". Lyon. |
2018-02-27 |
| Sartorius Stedim Biotech GmbH. (3/16/18). "Press Release: Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion". Göttingen. |
2018-03-16 |
| Novasep S.A.. (4/25/18). "Press Release: Novasep Announces 2017 Financial Results. Sales Are up 4% at 282 M€, EBITDA Is up 4.3% at 29 M€". Lyon. |
2018-04-25 |
| Novasep S.A.. (6/11/18). "Press Release: Novasep Launches BioSC Pilot, Breakthrough Chromatography and DSP Skid for Biologics Purification". Lyon. |
2018-06-11 |
| Dynacure SAS. (7/6/18). "Press Release: Dynacure Secures €47 Million Financing to Advance Lead Program into Clinical Development". Strasbourg. |
2018-07-06 |
| Polyplus-transfection S.A.. (7/6/18). "Press Release: Polyplus-transfection Launches New Advanced System for Transient Protein Expression in CHO cells". Strasbourg. |
2018-07-06 |
| Dynacure SAS. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg. |
2018-07-10 |
| Transgene S.A.. (8/20/18). "Press Release: Transgene Completes the Sale of the Greater China Rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 Million in Newly-Issued Shares". Strasbourg. |
2018-08-20 |
| Novasep S.A.. (8/21/18). "Press Release: Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s". Lyon. |
2018-08-21 |
| Novasep S.A.. (10/2/18). "Press Release: Novasep Opens €27m New Viral Vector Commercial Production Facility". Lyon. |
2018-10-02 |
| Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". |
2018-11-29 |
| Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour |
2018-12-04 |
| Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. |
2018-12-04 |
| Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg. |
2018-12-13 |
| ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. |
2019-01-17 |
| ImaBiotech SAS. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. |
2019-01-17 |
| Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. |
2019-02-27 |
| Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen. |
2019-03-05 |
| Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. |
2019-03-14 |
| Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. |
2019-03-27 |
| Genfit S.A.. (4/18/19). "Press Release: Genfit Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC". Lille & Boston, MA. |
2019-04-18 |
| Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg. |
2019-05-02 |
| Domain Therapeutics S.A.. (5/28/19). "Press Release: European Venture Capital Firm Seventure Partners Renews Its Support to Domain Therapeutics and Invests €3.5M ($3.9M) to Prepare the Next Growth Phase". Strasbourg. |
2019-05-28 |
| Genfit S.A.. (6/24/19). "Press Release: Genfit and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China". Lille & Cambridge, MA. |
2019-06-24 |
| Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg. |
2019-07-02 |
| Genfit S.A.. (9/2/19). "Press Release: Board of Directors, Represented by Chairman Jean-François Mouney, Appoints Pascal Prigent as New CEO". Lille & Cambridge, MA. |
2019-09-02 |
| Domain Therapeutics S.A.. (9/11/19). "Press Release: Domain Therapeutics Invests in Ermium Therapeutics to Develop First-in-class CXCR4 Candidate for Autoimmune Diseases". Strasbourg. |
2019-09-11 |
| Urania Therapeutics SAS. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg. |
2019-11-06 |
| Domain Therapeutics S.A.. (1/13/20). "Press Release: Domain Therapeutics Secures €6 Million ($6.7M) Debt Financing". Strasbourg. |
2020-01-13 |
| Urania Therapeutics SAS. (1/14/20). "Press Release: Urania Therapeutics Benefits from €1.7M Deeptech Financing from Bpifrance". Strasbourg. |
2020-01-14 |
| Polyplus-transfection S.A.. (4/29/20). "Press Release: Growth Investment Is Set to accelerate Polyplus’ Expansion in Partnership with Warburg Pincus and ArchiMed". Illkirch. |
2020-04-29 |
| Transgene S.A.. (5/4/20). "Press Release: Vaxxel Acquires Transgene’s DuckCelt-T17 Cell Line to Develop Industrial-scale Vaccines against Respiratory Viruses". Lyon & Strasbourg. |
2020-05-04 |
| Ynsect SAS. (10/6/20). "Press Release: Agtech Startup Ÿnsect Extends Its Series C to $372 Million to Improve Global Food Security and Sustainability with the First Carbon Negative and Largest Vertical Farm in the World". Paris. |
2020-10-06 |
| Polyplus-transfection S.A.. (11/2/20). "Press Release: Polyplus-transfection Names Mario Philips as Chief Executive Officer". Illkirch. |
2020-11-02 |
| Transgene S.A.. (12/3/20). "Press Release: Transgene Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer". Strasbourg. |
2020-12-03 |
| Satorius AG. (1/6/21). "Press Release: Sartorius to Acquire Novasep’s Chromatography Process Equipment Division". Göttingen. |
2021-01-06 |
| Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
| Novalix SAS. (1/25/21). "Press Release: Novalix Partners with Chemical.AI to Develop Artificial Intelligence Toolkit for Drug Discovery". Strasbourg & Wuhan. |
2021-01-25 |
| Cell-Easy. (3/29/21). "Press Release: Cell-Easy Strengthens Executive Team with Two New Highly Experienced Members". Toulouse. |
2021-03-29 |
| ImmunOs Therapeutics AG. (4/12/21). "Press Release: ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases". Schlieren. |
2021-04-12 |
| HypnoVR SAS. (7/19/21). "Press Release: HypnoVR – the First Virtual Reality Medical Hypnosis Solution for Reducing Patient Anxiety During Dental Treatment". |
2021-07-19 |
| Dominique Dutscher SAS. (8/3/21). "Press Release: Dutscher Announces the Acquisition of AH Diagnostics". |
2021-08-03 |
| Global Bioenergies S.A.. (10/20/21). "Press Release: Global Bioenergies Makes Breakthrough on the Road towards Biojet Fuel". Évry. |
2021-10-20 |
| Novalix SAS. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg. |
2021-11-30 |
| HypnoVR SAS. (12/7/21). "Press Release: HypnoVR Raises €4.5 Million to Accelerate the Roll Out of Its Digital Therapy Treating Pain and Anxiety". Strasbourg. |
2021-12-07 |
| Genfit S.A.. (12/17/21). "Press Release: Ipsen and Genfit Enter into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-term Global Partnership". Paris. |
2021-12-17 |
| Apmonia Therapeutics SAS. (2/10/22). "Press Release: Apmonia Therapeutics Announces a 4 M€ Fundraising Round to Complete Regulatory Preclinical Studies of Its Anti-cancer Immunotherapy Drug Candidate (AP-01)". Reims. |
2022-02-10 |
| Transgene S.A.. (2/10/22). "Press Release: Transgene Appoints Steven Bloom as Chief Business Officer". Strasbourg. |
2022-02-10 |
| Polyplus-transfection S.A.. (3/9/22). "Press Release: Polyplus-transfection Acquires Biowire to further Expand into Asia-Pacific Gene and Cell Therapy Markets". Strasbourg. |
2022-03-09 |
| XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". |
2022-03-29 |
| Core Biogenesis SAS. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". |
2022-03-29 |
| Hemerion Therapeutics SAS. (4/14/22). "Press Release: Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer". Villeneuve d’Ascq. |
2022-04-14 |
| Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert. |
2022-05-12 |
| Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. |
2022-05-12 |
| Core Biogenesis SAS. (7/28/22). "Press Release: Core Biogenesis Raises $10.5M to Accelerate Plant-Based Bioproduction". Strasbourg. |
2022-07-28 |
| NLC Ventures Netherlands B.V.. (9/8/22). "Press Release: AIDO, an NLC venture, Has Made It Its Mission to Bring more Control to Physicians Performing Endoscopic Procedures and Lower the Threshold to Expand Complex Interventions". |
2022-09-08 |
| Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. |
2022-09-19 |
| Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg. |
2022-12-15 |
| Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. |
2022-12-17 |
| Biper Therapeutics SAS. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg. |
2023-02-14 |
| ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. |
2023-03-27 |
| Galapagos N.V.. (3/30/23). "Press Release: Galapagos and Novalix Enter into an Integrated Drug Discovery Collaboration". Mechelen & Strasbourg. |
2023-03-30 |
| Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen. |
2023-03-31 |
| Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg. |
2023-05-05 |
| Flash Therapeutics SAS. (7/6/23). "Press Release: Flash Therapeutics Appoints Jérôme Bédier as Président to Accelerate Its Biopharmaceutical CDMO Business Development". Toulouse. |
2023-07-06 |
| Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford. |
2023-09-20 |
| Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg. |
2024-01-22 |
| SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris. |
2024-03-27 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
